肿瘤标记物,Tumor marker
1)Tumor marker肿瘤标记物
1.Clinical evaluation of five tumor markers in peripheral blood from patients with gastric cancer;胃癌患者外周血中五种肿瘤标记物测定的临床意义
2.Clinical utility of serum tumor markers in mature cystic teratoma of the ovary and its malignant transformation;血清肿瘤标记物测定在卵巢成熟畸胎瘤及其恶变者的临床应用
3.The determination and clinical evaluation of tumor markers in the patients with ovarian tumor;卵巢癌的肿瘤标记物测定与临床评价
英文短句/例句
1.Study on the Capillary Electrophoresis of Some Tumor Markers and Anticarcinogens;一些肿瘤标记物及抗肿瘤药物的毛细管电泳研究
2.Detection of tumor markers CEA and CA125 in pleural fluid for diagnosis of pulmonary malignancies胸水中肿瘤标记物CEA,CA125测定在肺部恶性肿瘤中诊断价值
3.Clinical indications of chemotherapy-induced tumor marker surge in advanced cancer patients晚期肿瘤患者化疗后肿瘤标记物一过性升高的临床意义
parative Study on Secretagogin, a Novel Neuroendocrine Marker, with the Former Markers新型神经内分泌肿瘤标记物-Secretagogin与以往标记物的比较研究
5.Update of Tumor Markers on Clinical Diagnosis and Treatment of Colorectal Cancer肿瘤标记物在大肠癌临床诊治中的应用进展
6.Clinical Significance of Combined Detection of Serum Tumor Markers in Lung Cancer Patients肺癌血清肿瘤标记物的联合检测及其临床意义
7.Identification of serum tumormarkers for diagnosing stage Ⅰ lung squamous cell carcinoma by MALDI-TOF mass spectrometryMALDI-TOF质谱技术筛选Ⅰ期肺鳞癌血清肿瘤标记物
8.Role of Combined Detection of Serum Tumor Markers in Diagnosis of Pancreatic Cancer肿瘤标记物联合检测对胰腺癌的诊断价值
9.Study on the Expression and Significance of Thy-1 as a Novel Tumor Marker in Hepatocelleular CarcinomaThy-1肿瘤标记物在肝癌的表达及意义研究
10.The clinical value of three kinds of tumor markers in patients with adnexal masses三项肿瘤标记物测定在附件包块中的临床价值
11.Study on the Anti Mullerian Hormone Served as a Marker for Granulosa Cell Tumorof Ovary抗苗勒管激素作为卵巢颗粒细胞瘤肿瘤标记物的实验研究
12.The Prognosis Factors on Local Resection of Uveal Melanoma and the Serum Markers of the Tumor;葡萄膜黑色素瘤局部切除预后影响因素及血清肿瘤标记物探讨
13.Set up Cerebral Spinal Fluid Protein Fingerprint Model for Diagnosis of Brain Malignant Glioma and Brain Metastasis and Select Potential Secreted Protein in CSF of Patients with Glioma;脑恶性胶质瘤患者脑脊液中候选肿瘤标记物蛋白质峰值研究
14.The diagnostic value of routine tumor markers in mature cystic teratomas of the ovary常规肿瘤标记物在卵巢成熟囊性畸胎瘤中的诊断意义
15.Screening and Identification of Gastric Carcinoma Associated Antigens and Serum Biomarkers by Immunoproteomics;利用免疫蛋白组学技术筛选和鉴定胃癌肿瘤相关抗原及血清肿瘤标记物
16.The Significance of Pleural Fluid Tumor Marker and LCT of Sputum in the Diagnosis of Lung Cancer;胸水肿瘤标记物检测及LCT痰检在肺癌诊断中的意义
17.The Evaluation of Interleukin-6 as a Tumor Sign in the Diagnosis and Prognosis of Ovary Cancer;白细胞介素-6作为卵巢癌诊断和预后判定肿瘤标记物的评价
18.Clinical Significance in Diagnosing Lung Cancer with the Combined Determination of Serum Tumor Markers;血清肿瘤标记物联合检测在肺癌诊断中的临床意义
相关短句/例句
tumor markers肿瘤标记物
1.Changes and significance oftumor markers in non-small cell lung cancer with chemotherapeutics;非小细胞肺癌化疗前后肿瘤标记物水平变化及意义
2.Diagnostic value of protein-chip by detectingtumor markers for lung cancer;肿瘤标记物蛋白芯片对肺癌的诊断价值
3.Clinical application and research oftumor markers in colorectal cancer;肿瘤标记物在结直肠癌中的临床应用和研究
3)tumor biomarkers肿瘤标记物
4)Biological tumor markers肿瘤生物标记物
5)Serum tumor marker血清肿瘤标记物
1.Purpose: To evaluate the combined application CT and serum tumor markers in diagnosis and staging ovarian carcinoma.目的:评价CT和血清肿瘤标记物联合检查在卵巢癌诊断与分期中的价值。
2.Objective:To assess the value of combined testing of serum tumor markers in the diagnosis of gallbladder carcinoma.目的 :观察胆囊癌患者血清肿瘤标记物的表达 ,分析血清肿瘤标记物联合检测在胆囊癌诊断中的作用。
3.Objective Carbohydrate antigen 50 (CA50) and 242 (CA242), recently recognized as serum tumor markers, are studied for their value in the diagnosis of the colorectal carcinoma.结论CA50和CA242的血清水平在结直肠癌中比结直肠良性疾病中为高,在结直肠癌的晚期比早期为高,对结直肠癌的临床诊断具有一定价值,可和其他血清肿瘤标记物联合检测,互相弥补以提高检出率;也可通过动态观察其血清水平,推测患者病情的进展。
6)tumor endothelial markers肿瘤内皮标记物
延伸阅读
肿瘤标记物肿瘤标记物是指肿瘤组织产生的可以反映肿瘤自身存在的化学物质,又称肿瘤标志物。这类物质可以是大分子的蛋白质(包括肽类激素和酶),也可以是小分子的脂类和氨基酸衍生物。理想的肿瘤标志物应该是肿瘤组织所特有而不存在于正常组织。然而迄今为止,还未找到这种正常组织中绝对不存在的肿瘤特异成分,故肿瘤标志物一般是指肿瘤组织和相应的正常组织相比,增高特别明显而有显著意义的化学成分。同一肿瘤可含有多种肿瘤标记物,而不同肿瘤或同种肿瘤的不同组织类型除有共同的标志物外,也可有不同的标志物。也即某一肿瘤的标志物对另一肿瘤来说不一定是标志物,而某一组织的正常产物对另一组织来源的肿瘤却可成为较好的肿瘤标志物。肿瘤标志物不仅可以用于肿瘤的诊断和鉴别,还可用于治疗效果的观察和预后的估计。在妇产科常用的肿瘤标记物包括蛋白质肿瘤标记物:甲胎蛋白(AFP)、癌胚抗原(CEA)、癌抗原CA125、CA153,鞘糖脂类肿瘤标记物CA199,激素类肿瘤标记物HCG等。